高效能液相层析市场 - 按产品类型（仪器、消耗品和配件）、按应用（临床研究应用、诊断应用、法医应用）、最终用途和预测，2024 年 - 2032 年

由于製药和生物技术研究中对精确、高效分析技术的需求不断增长，高性能液相层析市场规模在 2024 年至 2032 年间将实现 5.3% 的复合年增长率。慢性病的增加以及随之而来的对新药发现的需求正在推动製药业对先进 HPLC（高效液相层析）系统的需求。据报道，大约三分之一的成年人患有多种慢性病。

世界各地的监管机构也在对环境和食品中的污染物和污染物水平执行严格的指导方针，进一步需要可靠和灵敏的分析方法。检测微量污染物和掺假物的能力也使液相层析成为遵守这些法规不可或缺的工具。 HPLC 技术的不断进步，包括超高效液相层析 (UHPLC) 系统的开发和检测方法的改进，将进一步推动市场成长。

整个产业分为产品类型、应用、最终用户和地区。

消耗品和配件产品类型领域的 HPLC 市场预计到 2032 年将实现强劲成长，因为它们在支援连续运作和效率方面发挥着重要作用。色谱管柱、过滤器、样品瓶和溶剂等消耗品是分析中样品製备、分离和检测过程所需的关键组件。固定相等消耗品技术的进步也提高了色谱性能、灵敏度和重现性，进一步推动了该细分市场的成长。

就最终用途而言，由于在临床诊断和研究中发挥至关重要的作用，临床实验室领域的高性能液相层析市场预计在 2024 年至 2032 年期间将出现大幅复合年增长率。 HPLC 广泛应用于临床实验室，以高灵敏度和精确度分析生物标记、药物化合物、维生素、荷尔蒙和代谢物。它还使医疗保健专业人员能够有效地诊断疾病、监测治疗药物水平并进行药物动力学研究。

亚太地区高效液相层析产业将在2024年至2032年间实现强劲成长。这些国家也越来越关注药品生产中的药物发现、品质控制和监管合规性，刺激了区域市场的成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 分析结果准确度高
    • HPLC 技术的进步
    • HPLC 测试在药物审批中的重要性日益增加
    • 研发支出增加
  • 产业陷阱与挑战
    • 缺乏熟练的专业人员
    • HPLC 系统成本高
• 成长潜力分析
• 监管环境
• 技术景观
• 未来市场趋势
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032 年

• 主要趋势
• 仪器仪表
  • 高效液相层析系统
  • 泵浦
  • 侦测器
  • 其他仪器
• 耗材及配件
  • 专栏
    • 反相 HPLC 柱
    • 正相 HPLC 柱
    • 离子交换高效液相层析管柱
    • 其他高效液相层析管柱
  • 过滤器
  • 小瓶
  • 管
  • 其他耗材及配件

第 6 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 临床研究应用
• 诊断应用
• 法医应用
• 其他应用

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 製药和生物技术公司
• 临床实验室
• 学术研究机构
• 其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋
  • 中东和非洲其他地区

第 9 章：公司简介

• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• Gilson Incorporated
• Hamilton Company
• Hitachi High-Tech Corporation
• Merck KGaA
• Mitsubishi Chemical Group Corporation
• PerkinElmer Inc.
• Shimadzu Corporation
• Thermo Fisher Scientific
• Tosoh Corporation
• Waters

High-performance liquid chromatography market size will register a 5.3% CAGR between 2024 and 2032 driven by increasing demand for precise and efficient analytical techniques in pharmaceutical and biotechnological research. The rise in chronic diseases and the consequent need for novel drug discoveries is propelling the demand for advanced HPLC (high performance liquid chromatography) systems in the pharmaceutical industry. As per reports, around one-third of all adults experienced multiple chronic conditions.

Regulatory bodies worldwide are also enforcing stringent guidelines for contaminant and pollutant levels in the environment and food products, further necessitating reliable and sensitive analytical methods. The capability to detect trace amounts of contaminants and adulterants also makes liquid chromatography an indispensable tool for compliance with these regulations. The continuous advancements in HPLC technology, including the development of ultra-high-performance liquid chromatography (UHPLC) systems and improved detection methods will further drive the market growth.

The overall industry is divided into product type, application, end-user, and region.

HPLC market from the consumables & accessories product type segment is slated to record strong growth through 2032 due to their essential role in supporting continuous operation and efficiency. Consumables, such as columns, filters, vials, and solvents are critical components required for sample preparation, separation, and detection processes in analysis. Advancements in consumable technologies, such as stationary phases are also enhancing the chromatographic performance, sensitivity, and reproducibility, further driving the segment growth.

With respect to end-use, the high-performance liquid chromatography market from the clinical laboratories segment is projected to observe a substantial CAGR during 2024-2032 owing to the crucial role in clinical diagnostics and research. HPLC is widely utilized in clinical laboratories for analyzing biomarkers, pharmaceutical compounds, vitamins, hormones, and metabolites with high sensitivity and precision. It also enables healthcare professionals to diagnose diseases, monitor therapeutic drug levels, and conduct pharmacokinetic studies effectively.

Asia Pacific high-performance liquid chromatography industry will witness a robust growth rate between 2024 and 2032. Rapid economic development in countries like China, India, and Japan is spurring investments in pharmaceutical R&D activities, fueling the demand for advanced analytical technologies. These countries are also increasingly focusing on drug discovery, quality control, and regulatory compliance in pharmaceutical manufacturing, stimulating regional market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 High accuracy and precision in analytical results
    • 3.2.1.2 Advancements in HPLC technologies
    • 3.2.1.3 Growing importance of HPLC tests in drug approvals
    • 3.2.1.4 Rise in R&D spending
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Lack of skilled professionals
    • 3.2.2.2 High cost of HPLC systems
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technological landscape
• 3.6 Future market trends
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Instruments
  • 5.2.1 HPLC systems
  • 5.2.2 Pumps
  • 5.2.3 Detectors
  • 5.2.4 Other instruments
• 5.3 Consumables & accessories
  • 5.3.1 Columns
    • 5.3.1.1 Reverse-phase HPLC columns
    • 5.3.1.2 Normal-phase HPLC Columns
    • 5.3.1.3 Ion exchange HPLC columns
    • 5.3.1.4 Other HPLC columns
  • 5.3.2 Filters
  • 5.3.3 Vials
  • 5.3.4 Tubes
  • 5.3.5 Other consumables & accessories

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Clinical research applications
• 6.3 Diagnostic applications
• 6.4 Forensic applications
• 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Pharmaceutical & biotechnology companies
• 7.3 Clinical laboratories
• 7.4 Academic & research institutions
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Agilent Technologies Inc.
• 9.2 Bio-Rad Laboratories Inc.
• 9.3 Gilson Incorporated
• 9.4 Hamilton Company
• 9.5 Hitachi High-Tech Corporation
• 9.6 Merck KGaA
• 9.7 Mitsubishi Chemical Group Corporation
• 9.8 PerkinElmer Inc.
• 9.9 Shimadzu Corporation
• 9.10 Thermo Fisher Scientific
• 9.11 Tosoh Corporation
• 9.12 Waters